Sort
48,018 grants matching “immunotherapy”
Controlling Tumor Immune Escape in Pancreatic Cancer using a Dual T Cell Product Strategy
$1,348,474Juan Fernando Vera · Marker Therapeutics, Inc. · R44 · FY2025 · CA
SRC on Primary and Metastatic Tumors of the CNS
$1,347,498Duke University · P50 · FY2004 · NS
SRC on Primary and Metastatic Tumors of the CNS
$1,347,498Duke University · P50 · FY2005 · NS
T cell recognition of the MR1 presented microbial metabolome
$1,346,843Erin June Adams · University Of Chicago · R01 · FY2021 · AI
IL-2 Family Cytokines and Receptors-- Mechanisms of Regulation & Action
$1,346,666Warren J Leonard · National Heart, Lung, And Blood Institute · ZIA · FY2012 · HL
Host-Tumor Cell Interactions in Myeloma:
$1,346,410Kenneth C Anderson · Dana-Farber Cancer Inst · P01 · FY2008 · CA
ADULT THERAPEUTIC CLINICAL TRIALS PROGRAM IN AIDS
$1,346,097Beth Israel Medical Ctr (New York) · U01 · FY2002 · AI
IND-enabling Preclinical Studies for Aβ and Dual Aβ/Tau MultiTEP platform-based AD Vaccines
$1,346,072Michael G Agadjanyan · Institute For Molecular Medicine · U01 · FY2021 · AG
Effects of genetic polymorphism in MHC, KIR, and related loci on human disease
$1,345,829Mary N. Carrington · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Pediatric AIDS Clinical Trials Unit
$1,345,731Children'S Memorial Hospital (Chicago) · U01 · FY2002 · AI
Dissecting the mechanisms of HIV resistance in vivo to broadly neutralizing antibodies
$1,345,576Alon Herschhorn · University Of Minnesota · U01 · FY2025 · AI
Preclinical Development of Human Monoclonal Antibodies for Postexposure Treatment of Crimean-Congo Hemorrhagic Fever
$1,345,347Thomas William Geisbert · University Of Texas Med Br Galveston · R01 · FY2017 · AI
Clinical Research Correlatives Core
$1,345,055Kaska Wloka · Division Of Basic Sciences - Nci · ZIC · FY2023 · CA
Improving the Outcome of Patients with Chronic Myeloid Leukemia Through Medi
$1,344,917Jorge E Cortes · University Of Tx Md Anderson Can Ctr · P01 · FY2014 · CA
HAWAII ACTU - ADULT THERAPEUTIC CLINICAL TRIALS PROGRAM
$1,344,787University Of Hawaii At Manoa · U01 · FY2001 · AI
Immunotherapeutic Modulation of Peanut Allergy
$1,344,779Robert A Wood · Icahn School Of Medicine At Mount Sinai · U19 · FY2016 · AI
Humanized Antibodies Derived from Chimpanzee Fabs that Neutralize Dengue Viruses
$1,341,255Ching-Juh Lai · Niaid Extramural Activities · Z01 · FY2007 · AI
Pathogenesis and countermeasures of poxviruses, hemorrhagic fever viruses, MERS
$1,340,561Peter Jahrling · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
The Use of Cancer Vaccines and Combination Therapies
$1,340,516James W Hodge · Basic Sciences · Z01 · FY2007 · CA
Phase II trial of GM-CSF/sargramostim in Alzheimer's Disease
$1,340,244Huntington Potter · University Of Colorado Denver · R01 · FY2021 · AG
T cell recognition of the MR1 presented microbial metabolome
$1,340,169Erin June Adams · University Of Chicago · R01 · FY2022 · AI
Development of new antibody-based cancer therapies
$1,340,134Mitchell Ho · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
EPITOPE BASED DNA VACCINES FOR AIDS THERAPY
$1,339,852Idm Pharma, Inc. · P01 · FY2003 · AI
Immunobiology and immunotherapy of leukemia
$1,339,575Austin J Barrett · National Heart, Lung, And Blood Institute · ZIA · FY2013 · HL
Biomarkers and Therapeutic Targets in Tumor Microenvironment and Metastasis
$1,339,057Rosandra Kaplan · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA